leisure time -WSS

leisure time

author：hotspot 2025-09-07 00:14:39 - browse：321

STAT's Damian Garde speaks with Mikael Dolsten and Mathai Mammen, in New York on March 21, 2024 — From left to right, STAT's Damian Garde; Mikael Dolsten, chief scientific officer of Pfizer research and development; and Rose Loughlin, Moderna’s senior vice president of early research and development, discuss the future of pharma at the STAT 2024 Breakthrough Summit East. STAT

Drug development is more of a sprint than a marathon these days, thanks to more and better ways to target underlying biology and a more nuanced interpretation of precision medicine, three biotech leaders said at the STAT Breakthrough Summit East in New York Thursday.

“We used to say, well, you may spend five years in the research phase, another five in development. Now I see a project that takes one year of research, from an idea to studies,” said Mikael Dolsten, chief scientific officer and president of Pfizer research and development. “Time is life. You care about patients. And when the distance to run is long, it holds back the energy and the inspiration.”

Key to that success are transformative new technologies like messenger RNA, which powered vaccines developed by Pfizer with its partner BioNTech.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Humana cuts profit projections as Medicare Advantage costs soar

WSS

The tragedy of Johnson & Johnson’s Covid vaccine

Biotech venture capitalists face new demands from investors

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Francis Collins on trust in science and how Covid communications failed

Hospital chaplains balance Covid safety with patients’ spiritual needs

FDA clears AI tool for detecting skin cancer

hotspot

leisure time

knowledge

BioMarin wins approval for gene therapy to treat hemophilia A

eGenesis tests gene

The cancer drug shortage isn’t new — and neither are the solutions

Parkinson’s finding may lead to tests and, someday, treatments

What does generative AI mean for health care? We asked experts

EU regulator recommends expanding Mounjaro approval to obesity

Hollywood unions extend contract negotiations for actors

STAT Virtual Event: JPM Recap, Live!

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

EU regulator recommends expanding Mounjaro approval to obesity

explore

Medicare Advantage today, explained in one chart

AI generated plenty of interest at JPM but not a lot of trust

Think you might have Covid

Parkinson’s finding may lead to tests and, someday, treatments

Gene therapy denied for Afghan refugee whose father aided U.S.

FDA clears AI tool for detecting skin cancer

focus

explore

focus

hotspot